Skip to main content
. 2013 May 9;8(5):e62804. doi: 10.1371/journal.pone.0062804

Table 3. Clinical factors significantly associated with total brain tissue volume (mL) and WMH in multivariable regression models.

Brain Region Antecedent Model F statistic/Adjusted R2 Coefficient (95% CI) –Adjusted by PMA at MRI Model F statistic/Adjusted R2 Coefficient (95% CI) – Adjusted by TCVand PMA at MRI Model F statistic/Adjusted R2 Coefficient (95% CI) – Adjusted by Total Brain Tissue Volume and PMA at MRI
Total brain tissue Birth weight 18.87**/0.47 10.65 (6.50, 14.80)** 108.09**/0.86 NS NA NA
SGA status −22.99 (−36.72, −9.26)* NS NA
Duration parenteralnutrition (per 10d) −3.12 (−5.43, −0.80)* NS NA
Apnea/Caffeine therapy −33.35 (−51.75, −14.95)** NS NA
Seizures/Anticon-vulsant therapy −37.59 (−63.93, −11.25)* −17.84 (−31.60, −4.08) NA
WM injury on cranial US NS −22.72 (−33.31, −13.13)** NA
Pulmonary hemorrhage NS −37.78 (−57.18, −18.38)** NA
WMHa GI surgery 5.24**/NV 8.08 (2.28, 14.56)* 5.37*/NV 7.57 (1.89, 13.89)* 4.17*/NV 8.25 (2.35, 14.86)*
Severe ROP surgery 5.73 (2.01, 9.75)* 6.34 (2.51, 10.48)* 6.04 (2.14, 10.28)*

p = 0.01 *p<0.01 **p<0.001.

NS – not significant; NA – not applicable; NV – no value (because utilized robust regression).

a

Reported as a percentage mean difference in WMH to cerebral white matter volume (95% CI).